Literature DB >> 10722821

Results following surgery for recurrent Dupuytren's disease.

T F Roush1, P J Stern.   

Abstract

This study was designed to assess the subjective and objective results following surgery for recurrent Dupuytren's disease. Nineteen patients (28 fingers) were treated surgically for recurrent contracture and were located for follow-up analysis at a median of 4 years (range, 1-15 years). Seventeen of 28 recurrences involved the small finger and 16 patients had at least one component of Dupuytren's diathesis. For the purpose of analysis the patients were divided into 3 groups: group A (total active range of motion [TAM] < 150 degrees ) consisted of 7 digits treated with limited fasciectomy and interphalangeal arthrodesis, group B (TAM >/= 150 degrees ) consisted of 8 digits treated with dermatofasciectomy and full-thickness skin graft, and group C (TAM >/= 150 degrees ) consisted of 13 digits treated with fasciectomy and local flaps. Total active range of motion reflecting the preoperative, immediately postoperative, and final follow-up values revealed that group C (fasciectomy and local flap) was the only group to maintain a statistically significant TAM improvement from preoperative (205 degrees ) to final follow-up (230 degrees ) analysis. Dermatofasciectomy and full-thickness skin grafting did not prevent recurrent contracture (preoperative TAM = 175 degrees; final follow-up TAM = 150 degrees ). Thirteen patients had abnormal Semmes-Weinstein monofilament testing and 8 had abnormal 2-point discrimination. There were 3 anesthetic digits. Despite these findings, 18 of the 19 patients were unconditionally satisfied with their experience and would undergo the procedure again. Copyright 2000 by the American Society for Surgery of the Hand.

Entities:  

Mesh:

Year:  2000        PMID: 10722821     DOI: 10.1053/jhsu.2000.jhsu25a0291

Source DB:  PubMed          Journal:  J Hand Surg Am        ISSN: 0363-5023            Impact factor:   2.230


  11 in total

1.  Surgical complications associated with fasciectomy for dupuytren's disease: a 20-year review of the English literature.

Authors:  Keith Denkler
Journal:  Eplasty       Date:  2010-01-27

Review 2.  [Treatment of recurrent Dupuytren's disease].

Authors:  T Pillukat; L Walle; R Stüber; J Windolf; J van Schoonhoven
Journal:  Orthopade       Date:  2017-04       Impact factor: 1.087

3.  A systematic review of outcomes of fasciotomy, aponeurotomy, and collagenase treatments for Dupuytren's contracture.

Authors:  Neal C Chen; Ramesh C Srinivasan; Melissa J Shauver; Kevin C Chung
Journal:  Hand (N Y)       Date:  2011-03-01

Review 4.  Dupuytren's disease: current state of the art.

Authors:  Mark Henry
Journal:  Hand (N Y)       Date:  2014-03

5.  The Wide-Awake Approach to Dupuytren's Disease: Fasciectomy under Local Anesthetic with Epinephrine.

Authors:  Rebecca Nelson; Amanda Higgins; Joanie Conrad; Mike Bell; Don Lalonde
Journal:  Hand (N Y)       Date:  2009-11-10

Review 6.  Optimal functional outcome measures for assessing treatment for Dupuytren's disease: a systematic review and recommendations for future practice.

Authors:  Catherine Ball; Anna L Pratt; Jagdeep Nanchahal
Journal:  BMC Musculoskelet Disord       Date:  2013-04-10       Impact factor: 2.362

7.  Fibroblasts from phenotypically normal palmar fascia exhibit molecular profiles highly similar to fibroblasts from active disease in Dupuytren's Contracture.

Authors:  Latha Satish; William A LaFramboise; Sandra Johnson; Linda Vi; Anna Njarlangattil; Christina Raykha; John Michael Krill-Burger; Phillip H Gallo; David B O'Gorman; Bing Siang Gan; Mark E Baratz; Garth D Ehrlich; Sandeep Kathju
Journal:  BMC Med Genomics       Date:  2012-05-04       Impact factor: 3.063

8.  N-acetyl-L-cysteine abrogates fibrogenic properties of fibroblasts isolated from Dupuytren's disease by blunting TGF-beta signalling.

Authors:  Jürgen Kopp; Harun Seyhan; Bastian Müller; Johanna Lanczak; Elke Pausch; Axel M Gressner; Steven Dooley; R E Horch
Journal:  J Cell Mol Med       Date:  2006 Jan-Mar       Impact factor: 5.310

Review 9.  What are we measuring? A critique of range of motion methods currently in use for Dupuytren's disease and recommendations for practice.

Authors:  Anna L Pratt; Catherine Ball
Journal:  BMC Musculoskelet Disord       Date:  2016-01-13       Impact factor: 2.362

10.  50 years experience with Dupuytren's contracture in the Erlangen University Hospital--a retrospective analysis of 2919 operated hands from 1956 to 2006.

Authors:  Bernd Loos; Valerij Puschkin; Raymund E Horch
Journal:  BMC Musculoskelet Disord       Date:  2007-07-04       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.